Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00314405
Recruitment Status : Completed
First Posted : April 13, 2006
Last Update Posted : August 8, 2008
Information provided by:
University Hospital, Strasbourg, France

Brief Summary:
The aim of this study is to evaluate the performance of a double labelling method using isotope and methylene blue dye injection to localize precisely Sentinel Lymph Node (SLN) in a series of 100 patients with infiltrative breast cancer justifying SLN excision. Method and patients: SLN excision will be performed on 100 patients treated for infiltrative breast cancer. After preoperative methylene blue dye injection and lymphoscintigraphy, individual localization of the radioactive and stained nodes will be performed. After the surgery, SLN will be submitted to serial analysis and immunohistochemistry. A comparison of the two methods and an economical evaluation of the complete procedure will be performed.

Condition or disease Intervention/treatment Phase
Infiltrative Breast Cancer Drug: Methylene blue (1%) Drug: Rhenium sulfure Procedure: Surgical procedure Procedure: Anatomo-pathologic procedure Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.
Study Start Date : April 2006
Actual Primary Completion Date : April 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Primary Outcome Measures :
  1. Determination of an optimized protocol for SLN identification, with a double method using isotope and methylene blue dye injection.

Secondary Outcome Measures :
  1. Comparison of the results of SLN serial sectioning, with H&E and IHC staining
  2. Economical evaluation of SLN procedure.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients with infiltrative breast cancer (diagnosed pre-operatively by core biopsy)
  • approval and informed consent

Exclusion Criteria:

  • chemotherapy
  • locoregional radiotherapy
  • prevalent axillary lymph node

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00314405

Layout table for location information
Service de Gynécologie-Obstétrique, Hôpital Civil
Strasbourg, France, 67091
Sponsors and Collaborators
University Hospital, Strasbourg, France
Layout table for investigator information
Study Director: Jean-Pierre Bellocq, MD Hôpitaux Universitaires de Strasbourg

Layout table for additonal information Identifier: NCT00314405    
Other Study ID Numbers: 3157
First Posted: April 13, 2006    Key Record Dates
Last Update Posted: August 8, 2008
Last Verified: February 2008
Keywords provided by University Hospital, Strasbourg, France:
sentinel lymph node
breast cancer
methylene blue dye
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases
Methylene Blue
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action